🟢 Neurosense Therapeutics Ltd is trading 5.7% up today after notable insider buying by top executives

Neurosense Therapeutics Ltd is trading 5.7% up today at $0.74 following significant insider buying by the company's top leadership.

• On June 16, 2026, the CEO and CFO each purchased 250,000 ordinary shares at $0.80 per share through a private placement.
• The insider activity is being viewed as a strong vote of confidence in the company's trajectory, helping lift investor sentiment early in the June 18, 2026, session.